本文選題：mTOR + 雷帕霉素�。� 參考：《中南大學(xué)》2008年博士論文

【摘要】： 目的觀察哺乳動(dòng)物雷帕霉素靶蛋白(mammalian target ofrapamycin,mTOR)基因轉(zhuǎn)染NIH3T3成纖維細(xì)胞后細(xì)胞增殖情況及對(duì)分泌纖連蛋白(fibronectin,FN)的影響,并以雷帕霉素(rapamycin)進(jìn)行干預(yù),檢測(cè)Akt-mTOR-p70S6K信號(hào)通路中各信號(hào)分子及FN的表達(dá),以探討mTOR基因?qū)Τ衫w維細(xì)胞增殖及分泌FN的影響及機(jī)制。 方法以氯化鈣制備感受態(tài)細(xì)胞法制備感受態(tài)細(xì)胞并轉(zhuǎn)化pcDNA3.0-mTOR重組質(zhì)粒,培養(yǎng)擴(kuò)增后以堿裂解法抽提質(zhì)粒,經(jīng)酶切及DNA測(cè)序鑒定,然后通過(guò)電穿孔法將質(zhì)粒轉(zhuǎn)染NIH3T3成纖維細(xì)胞,以G418篩選,擴(kuò)大培養(yǎng)后獲得穩(wěn)定轉(zhuǎn)染細(xì)胞株。以雷帕霉素干預(yù)轉(zhuǎn)染細(xì)胞和非轉(zhuǎn)染細(xì)胞,采用MTT法檢測(cè)細(xì)胞增殖力,RT-PCR、Western blot等方法檢測(cè)細(xì)胞Akt、mTOR、p70S6K和FN的表達(dá)。應(yīng)用SPSS11.0統(tǒng)計(jì)軟件對(duì)數(shù)據(jù)進(jìn)行統(tǒng)計(jì)學(xué)分析,計(jì)量資料以(?)±s表示,組間比較采用t檢驗(yàn)和F檢驗(yàn);計(jì)數(shù)資料組間比較采用χ~2檢驗(yàn)。以P＜0.05為差別有顯著性統(tǒng)計(jì)學(xué)意義。 結(jié)果 (1)提取的質(zhì)粒濃度為296ng/μL,OD260/OD280為1.88。雙酶切鑒定可見(jiàn)目的基因片段,DNA測(cè)序進(jìn)一步證實(shí)為目的基因。 (2)mTOR基因轉(zhuǎn)染成纖維細(xì)胞后各基因及蛋白表達(dá)的檢測(cè)結(jié)果:mTOR mRNA表達(dá),mTOR/GAPDH光密度值在轉(zhuǎn)染組、對(duì)照組分別為0.68±0.03、0.38±0.03(P＜0.01);mTOR蛋白表達(dá),mTOR/GAPDH灰度值在轉(zhuǎn)染組、對(duì)照組分別為0.79±0.04和0.57±0.01(P＜0.01)。FN mRNA表達(dá),FN/GAPDH光密度值在轉(zhuǎn)染組、對(duì)照組分別為0.63±0.07、0.39±0.03(P＜0.01);FN蛋白表達(dá),FN/GAPDH灰度值在轉(zhuǎn)染組、對(duì)照組分別為0.77±0.07和0.55±0.04(P＜0.01)。Akt mRNA表達(dá),Akt/GAPDH光密度值在轉(zhuǎn)染組、對(duì)照組分別為0.41±0.07、0.39±0.02(P＞0.05);Akt蛋白表達(dá),Akt/GAPDH灰度值在轉(zhuǎn)染組、對(duì)照組分別為0.65±0.02和0.63±0.03(P＞0.05)。p70S6KmRNA表達(dá),p70S6K/GAPDH光密度值在轉(zhuǎn)染組、對(duì)照組分別為0.69±0.03、0.34±0.02(P＜0.01);p70S6K蛋白表達(dá),p70S6K/GAPDH灰度值在轉(zhuǎn)染組、對(duì)照組分別為0.75±0.06、0.53±0.05(P＜0.01)。MTT(A值)檢測(cè)結(jié)果:在各時(shí)間點(diǎn)A值轉(zhuǎn)染組大于對(duì)照組(P＜0.01)。 (3)雷帕霉素干預(yù)轉(zhuǎn)染前后檢測(cè)結(jié)果:Akt mRNA表達(dá):Akt/GAPDH光密度值在轉(zhuǎn)染組、對(duì)照組、雷帕霉素干預(yù)轉(zhuǎn)染組、雷帕霉素干預(yù)對(duì)照組分別為0.4±0.06、0.39±0.02、0.41±0.05、0.39±0.04。轉(zhuǎn)染組光密度值與其他三組及其他三組之間均無(wú)顯著性差異(P＞0.05)。Akt蛋白表達(dá):Akt/GAPDH灰度值在轉(zhuǎn)染組、對(duì)照組、雷帕霉素干預(yù)轉(zhuǎn)染組、雷帕霉素干預(yù)對(duì)照組分別為0.66±0.02、0.63±0.04、0.67±0.07、0.64±0.05,轉(zhuǎn)染組灰度值與其他三組及其他三組之間均無(wú)顯著性差異(P＞0.05)。p70S6K mRNA表達(dá):p70S6K/GAPDH光密度值在轉(zhuǎn)染組、對(duì)照組、雷帕霉素干預(yù)轉(zhuǎn)染組、雷帕霉素干預(yù)對(duì)照組分別為0.70±0.03、0.34±0.04、0.35±0.02、0.33±0.06。轉(zhuǎn)染組光密度值大于其他三組(P＜0.01),其他三組之間無(wú)顯著性差異(P＞0.05)。p70S6K蛋白表達(dá):p70S6K/GAPDH灰度值在轉(zhuǎn)染組、對(duì)照組、雷帕霉素干預(yù)轉(zhuǎn)染組、雷帕霉素干預(yù)對(duì)照組分別為0.76±0.05、0.54±0.04、0.52±0.01、0.53±0.03。轉(zhuǎn)染組灰度值大于其他三組(P＜0.01),其他三組之間無(wú)顯著差異(P＞0.05)。FN mRNA表達(dá):FN/GAPDH光密度值在轉(zhuǎn)染組、對(duì)照組、雷帕霉素干預(yù)轉(zhuǎn)染組、雷帕霉素干預(yù)對(duì)照組分別為0.64±0.04、0.40±0.05、0.40±0.03、0.41±0.03。轉(zhuǎn)染組光密度值大于其他三組(P＜0.01),其他三組之間無(wú)顯著差異(P＞0.05)。FN蛋白表達(dá):FN/GAPDH灰度值在轉(zhuǎn)染組、對(duì)照組、雷帕霉素干預(yù)轉(zhuǎn)染組、雷帕霉素干預(yù)對(duì)照組分別為0.76±0.03、0.53±0.01、0.54±0.02、0.54±0.05。轉(zhuǎn)染組灰度值大于其他三組(P＜0.01),其他三組之間無(wú)顯著性差異(P＞0.05)。MTT(A值)檢測(cè)結(jié)果:在各時(shí)間點(diǎn)A值轉(zhuǎn)染組大于雷帕霉素干預(yù)轉(zhuǎn)染組及對(duì)照組、雷帕霉素干預(yù)對(duì)照組(P＜0.01),后三組各時(shí)間點(diǎn)A值無(wú)顯著性差異(P＞0.05)。 結(jié)論 (1)mTOR基因使成纖維細(xì)胞增殖力增強(qiáng),FN表達(dá)增強(qiáng)。 (2)mTOR基因通過(guò)Akt-mTOR-p70S6K信號(hào)通路發(fā)揮作用,不一定依賴Akt的激活。 (3)雷帕霉素可通過(guò)阻斷mTOR-p70S6K信號(hào)通路而抑制成纖維細(xì)胞增殖及FN的合成。
[Abstract]:Objective To observe the proliferation of mammalian target ofrapamycin (mTOR) gene transfected by rapamycin ofrapamycin (mTOR) gene and the effect on the secretion of fibronectin (fibronectin, FN) in NIH3T3 fibroblasts, and to detect the expression of each signal molecule and FN in the Akt-mTOR-p70S6K signal pathway by using rapamycin (rapamycin) to detect the expression of each signal molecule and FN in the Akt-mTOR-p70S6K signal pathway. To explore the effect and mechanism of mTOR gene on proliferation and secretion of FN in fibroblasts.
Methods using calcium chloride to prepare susceptible cells and transform pcDNA3.0-mTOR recombinant plasmid, the plasmid was extracted by alkali lysis and identified by enzyme digestion and DNA sequencing. Then transfected by electroporation, the plasmid was transfected into NIH3T3 fibroblasts, and the stable transfected cell line was obtained by G418 screening. The cells and non transfected cells were transfected by MTT, and the expression of cell Akt, mTOR, p70S6K and FN were detected by RT-PCR and Western blot. The data were statistically analyzed with SPSS11.0 statistical software. The measurement data were expressed with (?) + s, t test and F test were used in the group, and the count data were compared by chi square The difference was statistically significant between P < 0.05.
Result
(1) the plasmid concentration was 296ng/ L, OD260/OD280 was 1.88., and the target gene fragment was identified by double enzyme digestion. DNA sequencing further confirmed the target gene.
(2) the detection results of gene and protein expression of mTOR gene transfected into fibroblasts: mTOR mRNA expression, mTOR/GAPDH light density value in transfection group and control group 0.68 + 0.03,0.38 + 0.03 (P < 0.01), mTOR protein expression, mTOR/GAPDH gray value in transfected group, and control group were 0.79 + 0.04 and 0.57 + 0.01 (P < 0.01).FN mRNA expression, respectively. FN/GAP The value of DH light density was 0.63 + 0.07,0.39 + 0.03 (P < 0.01) in the control group, and the expression of FN protein was expressed in the transfected group, and the control group was 0.77 + 0.07 and 0.55 + 0.04 (P < 0.01).Akt mRNA, respectively. The Akt/GAPDH light density value was in the transfected group, and the control group was 0.41 + 0.07,0.39 + 0.02 (P > 0.05), and the Akt protein was expressed. The value of gray value in the transfection group was 0.65 + 0.02 and 0.63 + 0.03 (P > 0.05).P70S6KmRNA respectively. The p70S6K/GAPDH light density value was 0.69 + 0.03,0.34 + 0.02 (P < 0.01) in the control group, and the p70S6K protein expression was expressed in the transfected group, and the p70S6K/GAPDH gray value was in the transfected group, and the group was 0.75 + 0.06,0.53 + 0.05 (P < 0.01).MTT (A), respectively. Results: at each time point, the A value transfection group was larger than that of the control group (P < 0.01).
(3) the results of rapamycin intervention before and after transfection: Akt mRNA expression: Akt/GAPDH light density value in transfection group, control group, rapamycin intervention group, the light density value of 0.4 + 0.06,0.39 + 0.02,0.41 + 0.05,0.39 + 0.04. transfection group with rapamycin control group, and no significant difference between the three groups and the other three groups (P > 0.05) The expression of.Akt protein: Akt/GAPDH gray value in transfection group, control group, rapamycin intervention group, rapamycin control group was 0.66 + 0.02,0.63 + 0.04,0.67 + 0.07,0.64 + 0.05 respectively, and there was no significant difference between the gray value of the transfected group and the other three groups and other three groups (P > 0.05).P70S6K mRNA expression: p70S6K/GAPDH light density value in the group The transfection group, control group, rapamycin intervention group, the light density value of 0.70 + 0.03,0.34 + 0.04,0.35 + 0.02,0.33 + 0.06. transfection group with rapamycin control group was greater than the other three groups (P < 0.01). There was no significant difference between the other three groups (P > 0.05).P70S6K protein expression: p70S6K/GAPDH gray value in transfection group, control group, rapamycin The gray value of 0.76 + 0.05,0.54 + 0.04,0.52 + 0.01,0.53 + 0.03. transfection group in the control group was greater than that of the other three groups (P < 0.01). There was no significant difference between the other three groups (P > 0.05).FN mRNA expression: the FN/GAPDH light density value was in the transfection group, the control group, the rapamycin intervention group, and the rapamycin intervention control The light density value of the group of 0.64 + 0.04,0.40 + 0.05,0.40 + 0.03,0.41 + 0.03. transfection group was greater than that of the other three groups (P < 0.01). There was no significant difference between the other three groups (P > 0.05).FN protein expression: the gray value of FN/GAPDH was in the transfection group, the control group, the rapamycin intervention group, the control group was 0.76 + 0.03,0.53 + 0.01,0.54 + 0., respectively. The gray value of 02,0.54 + 0.05. transfection group was greater than that of the other three groups (P < 0.01), there was no significant difference between the other three groups (P > 0.05).MTT (A value) detection results: at every time point, A value transfection group was greater than rapamycin intervention group and control group, rapamycin intervention control group (P < 0.01), and there was no significant difference between the three groups at each time point A value (P > 0.05).
conclusion
(1) mTOR gene increased the proliferation of fibroblasts and enhanced the expression of FN.
(2) mTOR gene plays a role through Akt-mTOR-p70S6K signaling pathway, and does not necessarily depend on Akt activation.
(3) rapamycin can inhibit fibroblast proliferation and FN synthesis by blocking mTOR-p70S6K signaling pathway.
【學(xué)位授予單位】：中南大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2008
【分類(lèi)號(hào)】：R346

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 劉凱;孫靈敏;劉建文;;雷帕霉素洗脫支架置入抑制豬TNF-α表達(dá)[J];基礎(chǔ)醫(yī)學(xué)與臨床;2011年09期

2 楊臻崢;;雷帕霉素或可延緩早老綜合征患者疾病進(jìn)程[J];藥學(xué)進(jìn)展;2011年07期

3 李芹芹;史道華;楊牛牛;;基于雷帕霉素與FRB結(jié)合的蛋白質(zhì)間相互作用的相關(guān)技術(shù)[J];生物技術(shù)通報(bào);2011年09期

4 劉錫君;李新;鄭水娣;鐘丹;章康健;王世兵;周秀梅;;雷帕霉素聯(lián)合ZD55-TRAIL病毒對(duì)腫瘤抑制及其機(jī)制探討[J];中國(guó)細(xì)胞生物學(xué)學(xué)報(bào);2011年06期

5 劉法昱;李鵬;趙震錦;丁雪;孫長(zhǎng)伏;;人頭頸鱗癌CCR7和mTOR表達(dá)關(guān)系研究[J];中國(guó)實(shí)用口腔科雜志;2011年07期

6 王德光;李學(xué)旺;李航;陳麗萌;段琳;李艷;劉華;;雷帕霉素對(duì)KKAy小鼠體重及胰島素抵抗的影響[J];中國(guó)糖尿病雜志;2007年02期

7 李敏娜;;新型免疫抑制劑雷帕霉素的研究進(jìn)展[J];河北化工;2011年08期

8 鄂亞軍;賀能樹(shù);范海倫;李志強(qiáng);;雷帕霉素局部緩釋對(duì)血管成形術(shù)后血管壁及其TF表達(dá)的影響[J];臨床放射學(xué)雜志;2011年08期

9 朱小青;;mTOR激活劑磷脂酸對(duì)SH-SY5Y細(xì)胞氧化應(yīng)激和Tau蛋白磷酸化的調(diào)節(jié)[J];中國(guó)病理生理雜志;2011年06期

10 齊曉云;徐萍;楊洋;李春華;王萬(wàn)糧;東洋;;血漿組織因子及其途徑抑制物對(duì)急性心肌梗死患者雷帕霉素支架置入后血栓形成的影響[J];中國(guó)醫(yī)科大學(xué)學(xué)報(bào);2011年07期

相關(guān)會(huì)議論文 前10條

1 張彤;梅長(zhǎng)林;付莉莉;熊錫山;王麗;戴兵;;驍悉和雷帕霉素對(duì)常染色體顯性多囊腎病治療作用的實(shí)驗(yàn)研究[A];2007年浙滬兩地腎臟病學(xué)術(shù)年會(huì)資料匯編[C];2007年

2 沈曉蕓;劉芳;唐乙;王全興;;雷帕霉素促進(jìn)Foxp3~+CD4~+CD25~+Treg細(xì)胞產(chǎn)生的分子機(jī)制[A];第六屆全國(guó)免疫學(xué)學(xué)術(shù)大會(huì)論文集[C];2008年

3 華雯;劉慧;夏麗霞;田寶平;陳志華;李雯;沈華浩;;雷帕霉素對(duì)哮喘小鼠骨髓嗜酸粒細(xì)胞祖細(xì)胞分化的影響[A];2011年第三十三屆浙江省呼吸系病學(xué)術(shù)年會(huì)暨呼吸疾病診治新進(jìn)展學(xué)習(xí)班論文匯編[C];2011年

4 趙妍敏;周倩;黃河;;雷帕霉素對(duì)Jurkat細(xì)胞作用及機(jī)制研究[A];2007年浙江省血液病學(xué)術(shù)年會(huì)論文匯編[C];2007年

5 李學(xué)旺;;雷帕霉素在慢性腎臟疾病治療中的作用[A];中華醫(yī)學(xué)會(huì)腎臟病學(xué)分會(huì)2006年學(xué)術(shù)年會(huì)專題講座[C];2006年

6 蔡勇;陳琰;鄭少玲;陳必成;夏鵬;楊亦榮;;雷帕霉素對(duì)于蛋白負(fù)荷腎病大鼠模型腎臟的影響[A];2007年浙江省器官移植學(xué)術(shù)會(huì)議論文匯編[C];2007年

7 張勝利;祝仕清;牛長(zhǎng)群;;國(guó)產(chǎn)雷帕霉素在恒河猴的藥代動(dòng)力學(xué)研究[A];2002年靈長(zhǎng)類(lèi)實(shí)驗(yàn)動(dòng)物學(xué)術(shù)交流會(huì)論文摘要集[C];2002年

8 程元榮;鄭衛(wèi);;新分子靶位mTOR與雷帕霉素類(lèi)藥物[A];創(chuàng)新藥物及新品種研究、開(kāi)發(fā)學(xué)術(shù)研討會(huì)論文集[C];2006年

9 尤慶生;陳宏林;孟小勇;;血管外雷帕霉素緩釋涂層抑制橋靜脈再狹窄的實(shí)驗(yàn)觀察[A];中華醫(yī)學(xué)會(huì)第七次全國(guó)胸心血管外科學(xué)術(shù)會(huì)議暨2007中華醫(yī)學(xué)會(huì)胸心血管外科青年醫(yī)師論壇論文集心血管外科分冊(cè)[C];2007年

10 董瑩;黃一飛;皮裕璃;;雷帕霉素對(duì)角膜移植術(shù)后VEGF的影響[A];中華醫(yī)學(xué)會(huì)第十二屆全國(guó)眼科學(xué)術(shù)大會(huì)論文匯編[C];2007年

相關(guān)重要報(bào)紙文章 前10條

1 本報(bào)記者 白毅;mTOR信號(hào)通路為腫瘤治療提供新靶點(diǎn)[N];中國(guó)醫(yī)藥報(bào);2010年

2 本報(bào)特約撰稿人 徐錚奎;雷帕霉素：新用途催生大市場(chǎng)[N];醫(yī)藥經(jīng)濟(jì)報(bào);2009年

3 駐京記者 李瑤;mTOR提供癌癥治療新思路[N];醫(yī)藥經(jīng)濟(jì)報(bào);2010年

4 歐颯;或許真有“長(zhǎng)壽藥”,但真能帶來(lái)快樂(lè)？[N];新華每日電訊;2009年

5 馬艷紅;雷帕霉素藥物釋放支架安全、有效[N];中國(guó)醫(yī)藥報(bào);2002年

6 實(shí)習(xí)生 李娜　本報(bào)記者 袁志勇;新發(fā)現(xiàn)可以阻斷腫瘤通路嗎[N];科技日?qǐng)?bào);2010年

7 方方;雷帕霉素藥物支架可降低冠心病再梗率[N];醫(yī)藥經(jīng)濟(jì)報(bào);2006年

8 本報(bào)記者 馮衛(wèi)東;雷帕霉素成為首種可延長(zhǎng)哺乳動(dòng)物壽命的藥物[N];科技日?qǐng)?bào);2009年

9 周婷玉　g品，

本文編號(hào)：2070270